NDC 64850-513 – Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate, and Amphetamine Sulfate

Dextroamphetamine Saccharate 5 mg/1; Dextroamphetamine Sulfate 5 mg/1; Amphetamine Aspartate Monohydrate 5 mg/1; Amphetamine Sulfate 5 mg/1 · Capsule, Extended Release · Oral

Human Prescription Drug DEA schedule CII

Product NDC64850-513

Product details

Brand name
Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate, and Amphetamine Sulfate
Generic name
Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate, and Amphetamine Sulfate
Labeler
Elite Laboratories, Inc.
Dosage form
Capsule, Extended Release
Route
Oral
Marketing category
ANDA · ANDA212037
Marketed since
December 16, 2019
Listing expires
December 31, 2027
Pharmacologic class
Central Nervous System Stimulant; Central Nervous System Stimulant; Central Nervous System Stimulant; Central Nervous System Stimulant

Active ingredients

Uses, dosage, side effects and warnings for Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate and Amphetamine Sulfate →

Package NDC codes (1)

Package NDCDescriptionSince
64850-513-01100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (64850-513-01)Dec 16, 2019

Other Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate and Amphetamine Sulfate products